NGS in CML - New standard diagnostic procedure?

NGS in CML - New standard diagnostic procedure?

Bibliographic Details
Main Authors:	Susan Branford, Naranie Shanmuganathan
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000199

Similar Items

Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia
by: Adelina Fernandes, et al.
Published: (2022-01-01)

Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
by: Shady Adnan Awad, et al.
Published: (2022-04-01)

S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
by: Chung Kok, et al.
Published: (2023-08-01)

Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib
by: Chung H. Kok, et al.
Published: (2023-09-01)

Optimization and standardization of mNGS-based procedures for the diagnosis of Mycoplasma periprosthetic joint infection: A novel diagnostic strategy for rare bacterial periprosthetic joint infection
by: Yuanqing Cai, et al.
Published: (2023-03-01)

The new European leukemianet recommendations for treating CML
by: Rüdiger Hehlmann
Published: (2020-10-01)

Nilotinib - new step of success in CML therapy
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Progress with interferon in CML--results of the MRC UK CML III study.
by: Shepherd, P, et al.
Published: (1996)

Editorial: mNGS for Fungal Pulmonary Infection Diagnostics
by: Henan Li
Published: (2022-03-01)

International CML forum
by: A. G. Turkina
Published: (2022-11-01)

Diagnostic Role of mNGS in Polymicrobial Periprosthetic Joint Infection
by: Jian Mei, et al.
Published: (2023-02-01)

Current treatment approaches in CML
by: Fausto Castagnetti, et al.
Published: (2019-06-01)

Characterization of the function of Calmodulin-like(CML) 23 and CML24 in the arabidopsis thaliana circadian clock /
by: Nur Izzati Mohd. Noh, author, et al.
Published: (2014)

New dosing schedules of dasatinib for CML and adverse event management
by: Wong Siu-Fun
Published: (2009-02-01)

Diagnostics of hereditary cancer syndromes by ngs. A database creation experience
by: Ivan S. Abramov, et al.
Published: (2021-10-01)

NGS DETERMINATION OF MYCOBACTERIAL TRANSRENAL DNA AS POTENTIAL TOOL OF CLINICAL DIAGNOSTIC
by: V. Sinkov, et al.
Published: (2018-12-01)

Clinical standardization of metagenomic next generation sequencing (mNGS) in the pathogen diagnosis
by: Mengjia Qian, et al.
Published: (2021-10-01)

CMLLite: a design philosophy for CML
by: Townsend Joe A, et al.
Published: (2011-10-01)

A New Image Encryption Algorithm Based on CML and DNA Sequence
by: Xingyuan Wang, et al.
Published: (2018-01-01)

Characterization of the function of Calmodulin-like(CML) 23 and CML24 in the arabidopsis thaliana circadian clock [electronic resource] /
by: Nur Izzati Mohd. Noh, author
Published: (2014)

Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB
by: Huiwen Zheng, et al.
Published: (2024-01-01)

Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems
by: Denis Horgan, et al.
Published: (2024-01-01)

PanelDesign: Integrating Epidemiological Information into the Design of Diagnostic NGS Gene Panels
by: Jörg Schmidtke, et al.
Published: (2022-04-01)

Phenotype-oriented NGS panels for mucopolysaccharidoses: Validation and potential use in the diagnostic flowchart
by: Ana Carolina Brusius-Facchin, et al.
Published: (2019-04-01)

Navigating the Rapids : The Development of NGS-based Clinical Trial Assays and Companion Diagnostics
by: Saumya ePant, et al.
Published: (2014-04-01)

P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12 DIRECT STUDY BASED ON TROUGH LEVELS MINIMISE TOXICITY AND PRESERVE EFFICACY
by: D. Yeung, et al.
Published: (2022-06-01)

Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms
by: Daniela Zizioli, et al.
Published: (2021-02-01)

CSI NGS Portal: An Online Platform for Automated NGS Data Analysis and Sharing
by: Omer An, et al.
Published: (2020-05-01)

Identifying regulators of chronic myeloid leukaemic (CML) stem cell quiescence and discovering effective novel therapies for CML relapse
by: Xu, Z
Published: (2022)

Hybrid Dynamic CML with Modified Current Source (H-MDyCML): A Low-Power Dynamic MCML Style
by: Riya Jain, et al.
Published: (2021-01-01)

PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML
by: N. Bouayed Abdelmoula, et al.
Published: (2022-06-01)

The expanding CML treatment landscape: an introspective commentary
by: Jeffrey H. Lipton
Published: (2023-09-01)

Comparison of the Transcriptomic Signatures in Pediatric and Adult CML
by: Minyoung Youn, et al.
Published: (2021-12-01)

CML ENGAGEMENT IN ENGLISH COMPETENCY FOR TVET EDUCATORS
by: Nor Yazi, Khamis, et al.
Published: (2024)

UNLEASHING THE POWER OF CML THE JOURNEY TO EKSA AWARD
by: Fathiah Izzati, Mohammad Fadzillah, et al.
Published: (2024)

Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
by: Jane Bugler, et al.
Published: (2019-07-01)

Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia
by: Torsten Haferlach
Published: (2020-09-01)

Novel Double Factor PGT strategy analyzing blastocyst stage embryos in a single NGS procedure.
by: Javier Del Rey, et al.
Published: (2018-01-01)

NGS in the clinical microbiology settings
by: Milena Pitashny, et al.
Published: (2022-10-01)

P713: REAL-WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML
by: G. Nesr, et al.
Published: (2022-06-01)